How We Broke a Global Life Sciences CMO Into the U.S. Market and Grew Traffic 263%

A contract manufacturing organization with worldwide reach had zero digital visibility in the United States. We changed that with a targeted SEO and content strategy built on WordPress, and the results reshaped their entire North American pipeline.

Entering a new market is hard enough when you have brand recognition on your side. For a global life sciences contract manufacturer competing against established domestic players, the challenge doubles. American buyers searching for pharmaceutical and biotech manufacturing partners almost never found this company online. Within twelve months, we built the digital foundation that put them in front of the right audience and grew their U.S. organic traffic by 263%.

Why U.S. Market Entry Matters for Global Life Sciences Companies

The United States accounts for roughly 45% of the global pharmaceutical market. For any contract manufacturing organization operating internationally, a weak American digital presence means missing the largest pool of potential partners and buyers. B2B decision-makers in pharma and biotech run online research long before they contact a vendor. If your website does not appear when they search for terms like “pharmaceutical contract manufacturer” or “biologics CMO services,” you are invisible at the exact moment that matters most.

We see this pattern repeatedly with international life sciences companies. They have strong reputations in Europe or Asia, a long client list, and ISO-certified facilities. But their websites were built for a different audience, and their content does not speak to the questions American buyers ask. That gap between offline credibility and online visibility is where opportunities disappear.

Five takeaways from this client story:

• Reputation alone does not cross borders: a strong track record overseas means little if U.S. buyers cannot find you through search
• Technical content builds trust faster than sales copy: pharmaceutical decision-makers want specifics about capabilities, compliance, and capacity before they ever fill out a contact form
• Site architecture shapes search performance: organizing service pages around how buyers actually search creates compounding organic growth
• WordPress gives global teams the flexibility they need: multilingual content, fast updates, and a CMS that non-technical staff can manage make WordPress the right fit for international companies scaling in new markets
• A 263% traffic increase came from strategy, not ad spend: organic growth driven by content and SEO produced higher-quality leads at a fraction of what paid channels cost

Who Was the Client?

The client is a contract manufacturing organization headquartered outside the United States with operations across multiple continents. They serve pharmaceutical companies, biotech startups, and medical device firms, offering services from formulation development through commercial-scale production. Their facilities hold FDA registration and multiple international certifications. In their home market and across Europe, the company had built a solid reputation over two decades of operation.

But in the U.S., they were starting from near zero in terms of digital presence.

What Was Holding Them Back Online?

The client’s existing website was built years earlier by an internal team, primarily for a European audience. It had several structural problems that blocked U.S. search visibility.

First, the site had no pages targeting American search behavior. Pharmaceutical buyers in the U.S. search differently than their European counterparts. They use specific terms like “cGMP contract manufacturer,” “sterile fill-finish services,” and “FDA-registered CMO.” The client’s site used none of this language. Second, the site architecture was flat. Service offerings were buried in PDFs and brochures rather than structured as indexable, keyword-targeted pages. Google could not crawl or categorize the content effectively.

Third, the client had zero backlink authority in the U.S. Their domain had links from European directories and industry publications, but almost nothing from American sources. From Google’s perspective, the site had no relevance to U.S. searches.

The net result: fewer than 200 organic visits per month from American users, and almost none of those visits converted into sales inquiries.

How Did We Build a U.S. Digital Presence from Scratch?

We started with research. Before writing a single page or touching the website, we mapped the full keyword and topic space for contract pharmaceutical manufacturing in the United States. Using Google Search Console data, competitor analysis, and tools like Semrush and Ahrefs, we identified over 340 relevant search terms grouped by buyer intent: informational queries from researchers, comparison queries from procurement teams, and transactional queries from decision-makers ready to request proposals.

“When a global company enters a new market digitally, the instinct is to translate what already exists. That almost never works. You have to rebuild the content strategy from the ground up, based on how buyers in that specific market search, evaluate, and decide.”

– Strategy Team at Emulent Marketing

With that research complete, we rebuilt the site on WordPress, hosted on WP Engine for speed, security, and reliability. The new site architecture grouped content into clear service categories: formulation development, clinical trial manufacturing, commercial production, packaging, and regulatory support. Each category received its own pillar page with supporting service-specific pages underneath. This structure gave Google a clear map of the site’s topical authority.

From there, we created a content calendar targeting the mid-funnel and top-funnel queries that American buyers use during their research phase. Articles covered topics like FDA compliance requirements for contract manufacturers, how to evaluate CMO capabilities for biologics, and what to expect during technology transfer. Each piece linked internally to relevant service pages, building topical clusters that reinforced the site’s authority on these subjects.

We also launched a focused backlink campaign. We placed contributed articles in U.S. life sciences trade publications, secured directory listings with organizations like ISPE and PDA, and built relationships with industry bloggers covering pharmaceutical supply chain topics. Over six months, the site earned 74 new referring domains from American sources.

What Did the Numbers Look Like After Twelve Months?

The results showed up in both traffic and business outcomes.

263% Increase in U.S. Organic Traffic

Monthly organic sessions from American users went from 187 to 679 within twelve months. By month fourteen, that number crossed 800 and continued climbing as older content gained traction in search results.

41 First-Page Rankings for High-Intent U.S. Keywords

The site moved from zero first-page positions for American search terms to 41, including competitive phrases like “pharmaceutical contract manufacturing USA” and “FDA-registered CMO services.”

74 New U.S.-Based Referring Domains

Backlink authority in the American market went from nearly nonexistent to a growing profile of relevant, high-quality links from trade publications and industry directories.

3.2x More Qualified Leads per Month

Contact form submissions from U.S. prospects more than tripled compared to the twelve months prior. The client’s sales team reported that lead quality improved as well, because visitors arriving through organic search already understood the company’s capabilities before reaching out.

What Can Other Life Sciences Companies Learn from This?

Global life sciences companies face a specific version of a common problem. They assume that a strong reputation and a functioning website are enough to compete digitally in a new geography. They are not.

American B2B buyers, especially in regulated industries like pharmaceuticals and medical devices, rely heavily on online research before engaging with potential vendors. A 2024 study by McKinsey found that 70% of B2B decision-makers prefer remote or digital interactions over in-person meetings during the early stages of vendor evaluation. If your site does not appear when those buyers search, and if the content does not answer their specific questions, you lose before you even know you were being considered.

“The companies that win in U.S. life sciences search are not always the biggest. They are the ones whose digital presence answers the exact questions buyers are asking at each stage of the decision process.”

– Strategy Team at Emulent Marketing

A few patterns we see across the industry worth noting. Many international CMOs underinvest in English-language content that targets American search terms. Others build websites on platforms that make updates slow and expensive, which means the site falls behind within a year of launch. And most do not track organic performance with enough detail to know which pages are driving leads versus which pages are just collecting passive traffic. Google Analytics and Google Search Console provide this data for free, but only if someone is reviewing it consistently and acting on what it reveals.

Ready to Grow Your Life Sciences Brand in the U.S. Market?

Breaking into a new market takes more than ambition. It takes a digital strategy built around how real buyers search, compare, and choose partners. We have done this work for global companies across regulated industries, and the approach adapts to where you are today, whether that means rebuilding a website, creating a U.S.-focused content strategy, or improving organic visibility for the keywords that drive revenue.

If your team is exploring digital marketing for life sciences companies, reach out to the Emulent Team. We will walk through your current visibility, identify the biggest gaps, and map out a plan that connects your capabilities to the buyers searching for them right now.